Comparisons between MM patients and normal BM donors have found that CD38 expression is higher on regulatory T cells (Tregs) than conventional T cells (Tcons), which allows CD38 mAbs to exert immunomodulatory effects through the reduction of Tregs.41, 42. Here, CD38 is linked to Miyoshi myopathy.